首页|AURKA对多发性骨髓瘤细胞增殖和凋亡及药物敏感性的影响及其机制

AURKA对多发性骨髓瘤细胞增殖和凋亡及药物敏感性的影响及其机制

扫码查看
目的 探讨AURKA对多发性骨髓瘤(MM)细胞增殖、凋亡、周期改变及对药物敏感性的影响,并分析内在机制.方法 人多发性骨髓瘤细胞株 RPMI8226 和 U266 分别转染 smart silencer NC(ssi-NC)和 smart silencer AURKA(ssi-AUR-KA),分为ssi-NC组、ssi-AURKA组和空白组,采用实时荧光定量聚合酶链式反应(qRT-PCR)和蛋白质印迹实验检测3组细胞AURKA mRNA和AURKA蛋白相对表达量,细胞计数试剂盒8(CCK8)检测其细胞增殖活性,流式细胞术检测ssi-NC组、ssi-AURKA组细胞周期变化和凋亡率,CCK 8法检测其对硼替佐米和地塞米松的药物敏感性,蛋白质印迹实验检测Wnt信号通路相关因子及上皮细胞-间充质转化(EMT)相关蛋白表达.结果 RPMI8226细胞ssi-AURKA组蛋白相对表达量为 0.58±0.09,低于空白组(1.00±0.10)和 ssi-NC 组(1.00±0.09),F=20.84,P<0.001;U266 细胞 ssi-AURKA 组蛋白相对表达量为0.57±0.07,低于空白组(1.00±0.04)和ssi-NC组(1.07±0.08),F=46.19,P<0.001.细胞增殖活性实验结果显示RPMI8226细胞空白组、ssi-NC组、ssi-AURKA组相对活性差异有统计学意义,F时间=3 966.12,P时间<0.001;F组别=363.15,P组别<0.001;F时间×组别=48.03,P时间×组别<0.001.U266 细胞空白组、ssi-NC 组、ssi-AURKA 组相对活性差异有统计学意义,F时间=2 452.32,P时间<0.001;F组别=236.91,P组别<0.001;F时间×组别=33.47,P时间×组别<0.001.RP-MI8226细胞和U266细胞中ssi-AURKA组S期均增加,t值分别为12.28和14.64,均P<0.001;G0/G1期均降低,t值分别为 23.33 和 22.98,均 P<0.001.RPMI8226 细胞(t=16.23,P<0.001)和 U266 细胞(t=18.44,P<0.001)中,与 ssi-NC 组比较,ssi-AURKA组细胞总凋亡率增加.药物敏感性实验结果显示,RPMI8226细胞ssi-NC组、ssi-AURKA组、ssi-NC+B+D组、ssi-AURKA+B+D组细胞活性差异有统计学意义,F时间=618.82,P时间<0.001;F组别=1 373.51,P组别<0.001;F时间×组别=228.70,P时间×组别<0.001.U266 细胞 ssi-NC组、ssi-AURKA组、ssi-NC+B+D组、ssi-AURKA+B+D组细胞活性差异有统计学意义,F时间=617.83,P时间<0.001;F组别=1 352.84,P组别<0.001;F时间×组别=155.81,P时间×组别<0.001.蛋白质印迹实验结果显示,RPMI8226 细胞中 ssi-AURKA 组 E-cadherin 表达升高,t=5.11,P=0.007;Vimentin、β-catenin 和Wnt3A 表达降低,t 值分别为 2.86、3.87 和 7.56,P 值分别为 0.046、0.018 和 0.002;U266 细胞中 ssi-AURKA 组 E-cadherin表达升高,t=10.02,P<0.001;Vimentin、β-catenin、Wnt3A 表达降低,t 值分别为 3.71、2.82 和 3.30,P 值分别为 0.020、0.047和0.030.结论 抑制AURKA表达可抑制MM细胞增殖,导致细胞周期的改变,诱导细胞凋亡,增加药物敏感性;AURKA可能通过Wnt/β-Catenin信号通路影响MM细胞EMT过程进而影响细胞增殖和凋亡.
Effect and mechanism of AURKA on proliferation,apoptosis and drug sensitivity of multiple myeloma cells
Objective To explore the effects of AURKA on proliferation,apoptosis,cycle changes and drug sensitivity of multiple myeloma(MM)cells,and analyze the underlying mechanisms.Method Human multiple myeloma cell lines RP-MI8226 and U266 were transfected with smart silent NC(ssi-NC)and smart silent AURKA(ssi-AURKA),respectively.They were divided into ssi-NC group,ssi-AURKA group and blank group.Real time fluorescence quantitative polymerase chain reaction(qRT-PCR)and western blotting were used to detect the relative expression levels of AURKA mRNA and AURKA protein in the three groups of cells.The cell proliferation activity was detected by CCK8 method,and the cell cycle changes and apoptosis rate were detected by flow cytometry in the ssi-NC group and ssi-AURKA group.The drug sensitivity to bortezomib and dexamethasone was evaluated by CCK 8 assay.Western blotting was performed to detect the expression of Wnt signaling pathway related factors and epithelial mesenchymal transition(EMT)related proteins.Results The relative expression level of ssi-AURKA histone in RPMI8226 cells was 0.58±0.09,lower than that of the blank group(1.00±0.10)and ssi-NC group(1.00±0.09),F=20.84,P<0.001;The relative expression level of ssi-AURKA histone in U266 cells was 0.57±0.07,lower than that of the blank group(1.00±0.04)and ssi-NC group(1.07±0.08),F=46.19,P<0.001.The results of the cell proliferation activity experiment showed that there was a statistically signifi-cant difference in the relative activity of RPMI8226 cells among the blank group,ssi-NC group and ssi-AURKA group,Ftime=3 966.12,Ptime<0.001;Fgroup=363.15,Pgroup<0.001;Ftime×group=48.03,Ptime×group<0.001.There was a statistical-ly significant difference in relative cell activity among the U266 cell blank group,ssi-NC group and ssi-AURKA group,with Ftime=2 452.32 and Ptime<0.001;Fgroup=236.91,Pgroup<0.001;Ftime×group=33.47,Ptime×group<0.001.The S phase of the ssi-AURKA group in RPMI8226 cells and U266 cells were increased,with t-values of 12.28 and 14.64,respectively,and both P<0.001;The G0/G1 phase showed a decrease,with t-values of 23.33 and 22.98,respectively,and both P<0.001.In RPMI8226 cells(t=16.23,P<0.001)and U266 cells(t=18.44,P<0.001),compared with the ssi-NC group,the total apoptosis rate of the ssi-AURKA group was increased.The results of drug sensitivity experiments showed that there was a statistically significant difference in cell activity among the ssi-NC group,ssi-AURKA group,ssi-NC+B+D group,and ssi-AURKA+B+D group of RPMI8226 cells,with Ftime=618.82 and Ptime<0.001;Fgroup=1 373.51,Pgroup<0.001;Ftime×group=228.70,Ptime×group<0.001.There was a statistically significant difference in cell activity among the ssi-NC group,ssi-AURKA group,ssi-NC+B+D group,and ssi-AURKA+B+D group of U266 cells,Ftime=617.83,Ptime<0.001;Fgroup=1 352.84,Pgroup<0.001;Ftime×group=155.81,Ptime×group<0.001.The results of the Western blot experiment showed that the expression of E-cadherin was increased in the ssi-AURKA group of RPMI8226 cells,t=5.11,P=0.007.The expression of Vimentin,β-catenin,and Wnt3A were decreased,with t values of 2.86,3.87 and 7.56,respectively,with P values of 0.046,0.018 and 0.002;In U266 cells,the expression of E-cadherin was increased in the ssi-AURKA group,with t=10.02 and P<0.001,while the expression of Vimentin,β-catenin,and Wnt3A were decreased,with t val-ues of 3.71,2.82,and 3.30 and P values of 0.020,0.047 and 0.030,respectively.Conclusions Inhibiting AURKA ex-pression can inhibit MM cell proliferation,lead to changes in cell cycle,induce cell apoptosis,and increase drug sensitivity;AURKA may affect the EMT process of MM cells and thereby influence cell proliferation and apoptosis through the Wnt/β-catenin signaling pathway.

multiple myelomaAURKAdrug resistanceproliferationapoptosisWnt signaling pathway

刘红春、黄睿、许腾、黄国虹

展开 >

新疆维吾尔自治区人民医院临床检验中心,新疆乌鲁木齐 830002

多发性骨髓瘤 AURKA 耐药 增殖 凋亡 Wnt信号通路

新疆维吾尔自治区自然科学基金面上项目新疆维吾尔自治区人民医院院内项目

2021D01C13520200209

2024

中华肿瘤防治杂志
中华预防医学会 山东省肿瘤防治研究院

中华肿瘤防治杂志

CSTPCD北大核心
影响因子:1.292
ISSN:1673-5269
年,卷(期):2024.31(14)